Cytoreductive Surgery and HIPEC: Patient Selection and Outcomes for Metastatic Colon Cancer

被引：0
|
作者：
TSeng, J. [1 ]
Alban, R. F. [1 ]
Gangi, A. [1 ]
Amersi, F. [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2019年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P157
引用
收藏
页码：S119 / S119
页数：1
相关论文
共 50 条
  • [41] Cytoreductive Surgery plus HIPEC for Peritoneal Metastases from Colorectal Cancer
    Bhatt A.
    Goéré D.
    Indian Journal of Surgical Oncology, 2016, 7 (2) : 177 - 187
  • [42] Current practice in cytoreductive surgery and HIPEC for metastatic peritoneal disease: Spanish multicentric survey
    Morales-Soriano, Rafael
    Esteve-Perez, Neus
    Jose Segura-Sampedro, Juan
    Cascales-Campos, Pedro
    Barrios, Pedro
    EJSO, 2018, 44 (02): : 228 - 236
  • [43] Cytoreductive Surgery and HIPEC for Regionally Advanced Gallbladder Cancer: a Case Report
    Fay Huang
    Raphael Shamavonian
    David L. Morris
    Indian Journal of Surgical Oncology, 2023, 14 : 127 - 130
  • [44] Cytoreductive surgery (CRS) and HIPEC in recurrent platinum resistant ovarian cancer
    Brown, C. K.
    Williams, S.
    McNutt, L.
    Beilick, S.
    Flynn, R.
    Litvack, D.
    Huss, H.
    Nair, A. R.
    Del Priore, G.
    GYNECOLOGIC ONCOLOGY, 2015, 137 : 114 - 114
  • [45] Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer
    Tentes, A. A. K.
    Palaskas, T. B.
    Stamou, K.
    Stoforos, C. E.
    Pallas, N.
    Karamveri, C.
    Kyziridis, D.
    Hristakis, C.
    Kyriakopoulos, V
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2019, 40 (01) : 48 - 54
  • [46] What Drives High Cytoreductive Surgery and HIPEC Costs: Patient, Provider or Tumor?
    Schwartz, P. B.
    Stahl, C. C.
    Stafford, L. M. Cherney
    Aiken, T. J.
    Barrett, J.
    Acher, A. W.
    Leverson, G.
    Ronnekleiv-Kelly, S.
    Weber, S.
    Abbott, D. E.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S117 - S117
  • [47] What Drives High Costs of Cytoreductive Surgery and HIPEC: Patient, Provider or Tumor?
    Patrick B. Schwartz
    Christopher C. Stahl
    Kara A. Vande Walle
    Courtney J. Pokrzywa
    Linda M. Cherney Stafford
    Taylor Aiken
    James Barrett
    Alexandra W. Acher
    Glen Leverson
    Sean Ronnekleiv-Kelly
    Sharon M. Weber
    Daniel E. Abbott
    Annals of Surgical Oncology, 2020, 27 : 4920 - 4928
  • [48] What Drives High Costs of Cytoreductive Surgery and HIPEC: Patient, Provider or Tumor?
    Schwartz, Patrick B.
    Stahl, Christopher C.
    Vande Walle, Kara A.
    Pokrzywa, Courtney J.
    Stafford, Linda M. Cherney
    Aiken, Taylor
    Barrett, James
    Acher, Alexandra W.
    Leverson, Glen
    Ronnekleiv-Kelly, Sean
    Weber, Sharon M.
    Abbott, Daniel E.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (13) : 4920 - 4928
  • [49] Intensive Care Management of Patient After Cytoreductive Surgery and HIPEC - A Concise Review
    Padmakumar A.V.
    Indian Journal of Surgical Oncology, 2016, 7 (2) : 244 - 248
  • [50] A novel preoperative risk score to optimize patient selection for performing concomitant liver resection with cytoreductive surgery/HIPEC.
    Lee, Rachel M.
    Gamboa, Adriana C.
    Turgeon, Michael K.
    Grotz, Travis Edward
    Fournier, Keith F.
    Dineen, Sean Patrick
    Veerapong, Jula
    Clarke, Callisia
    Patel, Sameer H.
    Henrix, Ryan James
    Lambert, Laura A.
    Abbott, Daniel Erik
    Raoof, Mustafa
    Johnston, Fabian McCartney
    Staley, Charles A.
    Cloyd, Jordan
    Maithel, Shishir K.
    Russell, Maria C.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (04)
12345